Calcifying Epithelial Odontogenic Tumor (CEOT), also known as a Pindborg tumor, is a rare, typically benign odontogenic neoplasm. However, rare malignant variants exist that pose significant diagnostic challenges. This report examines a case of malignant CEOT in a 56-year-old male, highlighting the difficulties in differentiating it from benign CEOT and squamous cell carcinoma (SCC) using cytology.
Case Progression and Metastasis
The patient initially presented with a CEOT in the left mandible. Despite surgical excision, the tumor recurred multiple times. By the third recurrence, histopathological analysis revealed features of malignancy, including increased mitotic activity (up to 21 per 10 high-power fields) and vascular invasion. Ultimately, the disease progressed to involve the right supraclavicular lymph nodes and the lungs, confirming its malignant nature.
Cytological Ambiguity
Fine-needle aspiration (FNA) cytology of the recurrent tumor showed a mix of small and large tumor cells. The cells exhibited high nucleus-to-cytoplasm (N/C) ratios, coarse chromatin, and prominent nucleoli.
These features are highly suggestive of malignancy but are problematic because benign CEOT can also display significant cellular atypia. This "cytological trap" makes it nearly impossible to definitively diagnose malignancy based on FNA alone. The authors emphasize that the greatest danger is misdiagnosing a benign CEOT as a common squamous cell carcinoma, which might lead to unnecessarily radical treatment.
Histopathological Transformation
While the primary tumor exhibited the classic features of CEOT—squamous-like cells, amyloid deposits, and calcification—these hallmarks were largely lost in the later malignant recurrences.
The transition from a well-defined benign tumor to an aggressive, poorly differentiated malignancy underscores the importance of longitudinal clinical monitoring. In this case, the loss of diagnostic markers like amyloid and calcification in later stages further complicated the pathological identification.
Conclusion
Distinguishing between benign and malignant CEOT via cytology remains extremely difficult. Because benign CEOT cells can look highly abnormal, there is currently no "smoking gun" in cytology that proves malignancy. In cases of suspected malignant CEOT, clinical evidence of recurrence and metastasis remains the most reliable indicator of malignancy.
Summary updated